Breitwieser Martin, Wiesner Teresa, Moore Vanessa, Wichlas Florian, Deininger Christian
Department for Orthopedic Surgery and Traumatology, Paracelsus Medical University, 5020 Salzburg, Austria.
J Clin Med. 2025 Feb 19;14(4):1397. doi: 10.3390/jcm14041397.
: Healthcare systems worldwide are increasingly burdened by rising costs, growing patient demand, and limited resources. In this context, cost-effectiveness analysis (CEA) plays a vital role in evaluating the clinical value of medical interventions relative to their costs. Despite the lack of evidence supporting their necessity, routine post-removal chest X-rays for central venous catheters (CVCs) are still performed in some hospitals due to persistent misconceptions about their benefits. This study seeks to address these misconceptions by examining the costs of routine imaging through a cost analysis of complication detection rates in a large inpatient cohort, with the aim of highlighting the inefficiencies of this practice and promoting evidence-based approaches. : A retrospective cohort analysis was performed across four university hospitals in Salzburg, Austria, including 984 CVC removals conducted between 2012 and 2021. Comparisons were made between X-rays after primary catheter insertion and post-removal X-rays to isolate complications specifically associated with CVC removal. A simple cost-per-outcome analysis, a subtype of CEA, was chosen to determine the cost per complication detected. The approach incorporated activity-based costing, adjusted to 2024 price levels via the Austrian Consumer Price Index (CPI), to capture real-world resource utilization. : Complications related to CVC removal were identified in five cases (0.5%), including one catheter rupture due to self-removal, two failed removals, one hemothorax, and one case of intrathoracic bleeding. Of these, three complications were detected on X-rays, including a retained catheter fragment, signs of intrathoracic bleeding, and a hemothorax. Additionally, one asymptomatic patient had a likely incidental finding of a small pneumothorax, which required no intervention. The cost of routine X-rays was calculated at EUR 38.20 per X-ray, resulting in a total expenditure of EUR 37,588.80 for 984 X-rays. This corresponds to EUR 7517.76 per detected complication ( = 4). The odds of detecting a complication on an X-ray were 193 times higher in symptomatic patients than in asymptomatic patients ( < 0.001). : This study confirms that complications following CVC removal are rare with only five detected cases. Routine imaging did not improve clinical decision-making, as complications were significantly more likely to be identified in symptomatic patients through clinical evaluation alone. Given the high financial cost (EUR 37,588.80 for 984 X-rays, EUR 7517.76 per detected complication), routine post-removal X-rays are unnecessary in asymptomatic patients and should be reserved for symptomatic cases based on clinical judgment. Adopting a symptom-based imaging approach would reduce unnecessary healthcare costs, minimize patient radiation exposure, and optimize resource allocation in high-volume procedures such as CVC removal.
全球医疗保健系统正日益受到成本上升、患者需求增长和资源有限的困扰。在此背景下,成本效益分析(CEA)在评估医疗干预措施相对于其成本的临床价值方面发挥着至关重要的作用。尽管缺乏证据支持其必要性,但由于对其益处存在持续误解,一些医院仍对中心静脉导管(CVC)常规进行拔除后胸部X光检查。本研究旨在通过对一大群住院患者并发症检测率进行成本分析,研究常规成像的成本,以解决这些误解,目的是突出这种做法的低效性并推广基于证据的方法。
在奥地利萨尔茨堡的四家大学医院进行了一项回顾性队列分析,包括2012年至2021年期间进行的984次CVC拔除。对初次导管插入后X光检查和拔除后X光检查进行比较,以分离出与CVC拔除特别相关的并发症。选择了一种简单的每结果成本分析(CEA的一种亚型)来确定检测到的每种并发症的成本。该方法采用作业成本法,并通过奥地利消费者价格指数(CPI)调整到2024年价格水平,以反映实际资源利用情况。
在5例(0.5%)患者中发现了与CVC拔除相关的并发症,包括1例因自行拔除导致的导管破裂、2例拔除失败、1例血胸和1例胸腔内出血。其中,3例并发症在X光检查中被发现,包括残留导管碎片、胸腔内出血迹象和血胸。此外,1例无症状患者可能偶然发现小气胸,无需干预。常规X光检查的成本计算为每次X光38.20欧元,984次X光检查的总支出为37588.80欧元。这相当于每检测到1例并发症7517.76欧元(=4)。有症状患者在X光检查中检测到并发症的几率比无症状患者高193倍(<0.001)。
本研究证实,CVC拔除后的并发症很少见,仅发现5例。常规成像并未改善临床决策,因为仅通过临床评估,有症状患者更有可能发现并发症。鉴于高昂的财务成本(984次X光检查为37588.